U.S. market Closed. Opens in 2 hours 56 minutes

CMRA | Comera Life Sciences Holdings, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-31
Revenue633.10K319.83K442.92K
Cost of Revenue210.39K161.01K104.41K
Gross Profit422.71K158.82K338.51K
Operating Expenses12.39M5.69M2.47M
Selling, General & Admin10.65M3.94M1.20M
Research & Development1.74M1.75M1.26M
Other Operating Expenses-1.46M-76.74K2.03K
Operating Income-11.97M-5.54M-2.13M
Other Expenses / Income-6.03M83.85K2.03K
Before Tax Income-18.00M-5.45M-2.13M
Income Tax Expenses6.03M-160.59K-116.55K
Net Income-24.04M-5.29M-2.13M
Interest Expenses20.39KN/AN/A
Basic Shares Outstanding10.45M19.09M19.09M
Diluted Shares Outstanding10.45M19.09M19.09M
EBITDA-13.33M-5.61M-2.04M
EBITDA Margin-2,105.79%-1,754.07%-460.08%
EBIT-17.98M-5.45M-2.24M
EBIT Margin-2,840.57%-1,704.58%-506.20%
Financial Year End2022-12-312021-12-312020-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙